Eagle Pharmaceuticals
EGRX
#9801
Rank
C$13.61 M
Marketcap
$1.05
Share price
-11.76%
Change (1 day)
-91.99%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : C$0.21 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eagle Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$0.23 B137.81%
2021-12-31C$98.48 M14.98%
2020-12-31C$85.65 M-12.99%
2019-12-31C$98.45 M-7.15%
2018-12-31C$0.10 B-7.23%
2017-12-31C$0.11 B34.81%
2016-12-31C$84.78 M78.4%
2015-12-31C$47.52 M
2014-09-30C$22.67 M36.99%
2013-09-30C$16.54 M-21.84%
2012-09-30C$21.17 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$151.49 B 70,673.39%๐Ÿ‡บ๐Ÿ‡ธ USA
C$83.62 B 38,964.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$84.18 B 39,225.97%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$49.56 B 23,053.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
C$116.79 B 54,458.78%๐Ÿ‡บ๐Ÿ‡ธ USA
C$85.86 B 40,013.50%๐Ÿ‡บ๐Ÿ‡ธ USA
C$107.14 B 49,951.71%๐Ÿ‡บ๐Ÿ‡ธ USA